Search Results - david+johnson

12 Results Sort By:
Mitochondrial-Targeted Peptide Modulators of Delta Protein Kinase C Interaction with the d-subunit of F1Fo ATP Synthase/ATPase as Therapeutics Against Cardiac Injury
Current State of the Art: Current clinical therapy for heart attack victims focuses on the rapid restoration of blood flow by thrombolysis, angioplasty, stenting and when appropriate surgical coronary artery bypass grafts. Problems with the Current Art: The majority of cardiac cell death associated with a heart attack actually occurs during the...
Published: 4/29/2020   |   Inventor(s): John Johnson, Tiffany Tuyen Nguyen, Mourad Ogbi
Keywords(s): Cardiovascular, Heart Attack, Therapeutics
Category(s): Therapeutics
2019-356 Model to predict transition from fee for service to bundled payments
Financial Model for Informing Value-Based Payment DecisionsTech ID: 30357 / UC Case 2019-356-0SUMMARYResearchers led by David Johnson from the Department of Urologic Oncology and the West Los Angeles Veteran’s Affairs Medical Center have developed an interactive web platform that predicts the financial outcomes for various stakeholders (physicians,...
Published: 7/19/2023   |   Inventor(s): David Johnson, Fernanda Bravo
Keywords(s): Software, Software & Algorithms
Category(s): Software & Algorithms, Software & Algorithms > Programs
Rabbit polyclonal antibody directed against human cytomegalovirus protein UL131
Technology Overview Rabbit polyclonal antisera against human cytomegalovirus (CMV) protein UL131 has been developed. This antisera is useful for research involving CMV. Please refer to the following publication for more information on this antisera. Aliquot provided: 0.5mL aliquots are provided. A minimum of three (3) aliquots of any combination of...
Published: 9/26/2023   |   Inventor(s): David Johnson
Keywords(s): Biological Materials, Biological Materials - Antibodies, Research Tools, Research Tools - Reagents
Category(s): Biological Materials
Rabbit polyclonal antibody directed against human cytomegalovirus protein UL130
Technology Overview Rabbit polyclonal antisera against human cytomegalovirus (CMV) protein UL130 has been developed. This antisera is useful for research involving CMV. Please refer to the following publication for more information on this antisera. Aliquot provided: 0.5mL aliquots are provided. A minimum of three (3) aliquots of any combination of...
Published: 9/26/2023   |   Inventor(s): David Johnson
Keywords(s): Biological Materials, Biological Materials - Antibodies, Research Tools, Research Tools - Reagents
Category(s): Biological Materials
Rabbit polyclonal antibody directed against human cytomegalovirus protein UL128
Technology Overview Rabbit polyclonal antisera against human cytomegalovirus (CMV) protein UL128 has been developed. This antisera is useful for research involving CMV. Please refer to the following publication for more information on this antisera. Aliquot provided: 0.5mL aliquots are provided. A minimum of three (3) aliquots of any combination of...
Published: 9/26/2023   |   Inventor(s): David Johnson
Keywords(s): Biological Materials, Biological Materials - Antibodies, Research Tools, Research Tools - Reagents
Category(s): Biological Materials
Rabbit polyclonal antibody directed against human cytomegalovirus protein gL
Technology Overview Rabbit polyclonal antisera against human cytomegalovirus (CMV) protein gL has been developed. This antisera is useful for research involving CMV. Please refer to the following publication for more information on this antisera. Aliquot provided: 0.5mL aliquots are provided. A minimum of three (3) aliquots of any combination of polyclonal...
Published: 9/26/2023   |   Inventor(s): David Johnson
Keywords(s): Biological Materials, Biological Materials - Antibodies, Research Tools, Research Tools - Reagents
Category(s): Biological Materials
Rabbit polyclonal antibody directed against human cytomegalovirus protein gH
Technology Overview Rabbit polyclonal antisera against human cytomegalovirus (CMV) protein gH has been developed. This antisera is useful for research involving CMV. Please refer to the following publication for more information on this antisera. Aliquot provided: 0.5mL aliquots are provided. A minimum of three (3) aliquots of any combination of...
Published: 9/26/2023   |   Inventor(s): David Johnson
Keywords(s): Biological Materials, Biological Materials - Antibodies, Research Tools, Research Tools - Reagents
Category(s): Biological Materials
Rabbit polyclonal antibodies directed against HCMV proteins gH, gL, UL128, UL130 and UL131
Technology Overview Rabbit polyclonal antibodies against human cytomegalovirus (CMV) proteins gH, gL, UL128, UL130 and UL131 have been developed. These are useful for research involving CMV. Please refer to the following publication for more information on these antibodies. Publication Ryckman B.J. “Characterization of the Human Cytomegalovirus...
Published: 12/26/2023   |   Inventor(s): David Johnson
Keywords(s): Biological Materials, Biological Materials - Antibodies, Research Tools, Research Tools - Reagents
Category(s): Biological Materials, Research Tools
Low Thermal Conductivity Misfit Layer Compounds
Misfit layer compounds are constructed of two interwoven repeating layers, resulting in materials which exhibit extremely low thermal conductivity. Potential applications include use as small-scale thermoelectric or insulating materials. Go to the Office of Technology Transfer
Published: 10/1/2021   |   Inventor(s): David Johnson, Ngoc Nguyen, Qiyin Lin, Colby Heideman
Keywords(s): Chemical, Materials Science, Nanoscience & Microtechnologies, ONAMI
Category(s): Nanoscience & Microtechnologies
Turbostratically Disordered Thermoelectric Materials
Turbostratically disordered inorganic materials which exhibit surprisingly low thermal conductivity and have potential to be used as thermoelectric materials. U.S. Patent Application No. 12/090,849. Go to the Office of Technology Transfer
Published: 10/29/2024   |   Inventor(s): David Johnson, Ngoc Nguyen
Keywords(s): Chemical, Materials Science, Nanoscience & Microtechnologies, ONAMI
Category(s): Nanoscience & Microtechnologies
1 2